# Republic Bancorp Inc: financial statements, quarterly

RBCAA · Nasdaq · CIK 921557 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rbcaa.md) · [Financials](/companies/rbcaa/financials.md) · [Filings](/companies/rbcaa/filings.md) · [Insiders](/companies/rbcaa/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rbcaa/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [79.2](/filings/0001558370-24-014810.md) | [81.6 d](/filings/0001104659-26-024523.md) | [120](/filings/0001558370-25-006869.md) | [86.9](/filings/0001558370-25-010682.md) | [88.1](/filings/0001104659-25-107626.md) | [89.5 d](/filings/0001104659-26-024523.md) | [136](/filings/0001104659-26-057076.md) | [93.8](/filings/0001104659-26-092605.md) | [93.5](/filings/0001104659-25-107626.md) | [94.3 d](/filings/0001104659-26-024523.md) | [120](/filings/0001104659-26-057076.md) | [101](/filings/0001104659-26-092605.md) |
| Interest expense | $m | [21.0](/filings/0001558370-23-017570.md) | [24.0 d](/filings/0001558370-24-003170.md) | [33.7](/filings/0001558370-24-007501.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [5.5](/filings/0001558370-24-014810.md) | [3.9 d](/filings/0001104659-26-024523.md) | [8.1](/filings/0001558370-25-006869.md) | [6.9](/filings/0001558370-25-010682.md) | [7.3](/filings/0001104659-25-107626.md) | [4.0 d](/filings/0001104659-26-024523.md) | [12.7](/filings/0001104659-26-057076.md) | [8.9](/filings/0001104659-26-092605.md) | [8.0](/filings/0001104659-25-107626.md) | [4.8 d](/filings/0001104659-26-024523.md) | [12.8](/filings/0001104659-26-057076.md) | [9.7](/filings/0001104659-26-092605.md) |
| Net income | $m | [21.6](/filings/0001558370-24-014810.md) | [19.7 d](/filings/0001104659-26-024523.md) | [30.6](/filings/0001558370-25-006869.md) | [25.2](/filings/0001558370-25-010682.md) | [26.5](/filings/0001104659-25-107626.md) | [19.0 d](/filings/0001104659-26-024523.md) | [47.3](/filings/0001104659-26-057076.md) | [31.5](/filings/0001104659-26-092605.md) | [29.7](/filings/0001104659-25-107626.md) | [22.8 d](/filings/0001104659-26-024523.md) | [42.6](/filings/0001104659-26-057076.md) | [32.9](/filings/0001104659-26-092605.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [220](/filings/0001558370-23-017570.md) | [317](/filings/0001558370-25-002370.md) | [546](/filings/0001558370-24-007501.md) | [400](/filings/0001558370-24-011581.md) | [531](/filings/0001558370-24-014810.md) | [432](/filings/0001104659-26-024523.md) | [793](/filings/0001558370-25-006869.md) | [485](/filings/0001558370-25-010682.md) | [484](/filings/0001104659-25-107626.md) | [220](/filings/0001104659-26-092605.md) | [599](/filings/0001104659-26-057076.md) | [354](/filings/0001104659-26-092605.md) |
| Total assets | $m | [6,386](/filings/0001558370-24-014810.md) | [6,595](/filings/0001104659-26-024523.md) | [6,876](/filings/0001558370-25-006869.md) | [6,617](/filings/0001558370-25-010682.md) | [6,692](/filings/0001104659-25-107626.md) | [6,847](/filings/0001104659-26-024523.md) | [7,076](/filings/0001104659-26-057076.md) | [6,971](/filings/0001104659-26-092605.md) | [7,015](/filings/0001104659-25-107626.md) | [7,042](/filings/0001104659-26-092605.md) | [7,253](/filings/0001104659-26-057076.md) | [7,062](/filings/0001104659-26-092605.md) |
| Total liabilities | $m | [5,493](/filings/0001558370-23-017570.md) | [5,682](/filings/0001558370-25-002370.md) | [5,940](/filings/0001558370-24-007501.md) | [5,661](/filings/0001558370-24-011581.md) | [5,713](/filings/0001558370-24-014810.md) | [5,855](/filings/0001104659-26-024523.md) | [6,041](/filings/0001558370-25-006869.md) | [5,911](/filings/0001558370-25-010682.md) | [5,930](/filings/0001104659-25-107626.md) | [5,940](/filings/0001104659-26-092605.md) | [6,120](/filings/0001104659-26-057076.md) | [5,905](/filings/0001104659-26-092605.md) |
| Shareholders' equity | $m | [893](/filings/0001558370-24-014810.md) | [913](/filings/0001104659-26-024523.md) | [936](/filings/0001558370-25-010682.md) | [955](/filings/0001104659-25-107626.md) | [980](/filings/0001104659-25-107626.md) | [992](/filings/0001104659-26-092605.md) | [1,034](/filings/0001104659-26-092605.md) | [1,060](/filings/0001104659-26-092605.md) | [1,085](/filings/0001104659-25-107626.md) | [1,102](/filings/0001104659-26-092605.md) | [1,133](/filings/0001104659-26-092605.md) | [1,157](/filings/0001104659-26-092605.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [21.4 d](/filings/0001558370-24-014810.md) | [22.3 d](/filings/0001104659-26-024523.md) | [71.2](/filings/0001558370-25-006869.md) | [4.0 d](/filings/0001558370-25-010682.md) | [51.3 d](/filings/0001104659-25-107626.md) | [22.5 d](/filings/0001104659-26-024523.md) | [89.1](/filings/0001104659-26-057076.md) | [8.4 d](/filings/0001104659-26-092605.md) | [37.4 d](/filings/0001104659-25-107626.md) | [33.3 d](/filings/0001104659-26-024523.md) | [73.0](/filings/0001104659-26-057076.md) | [1.1 d](/filings/0001104659-26-092605.md) |
| Capital expenditure | $m | [1.7 d](/filings/0001558370-24-014810.md) | [1.6 d](/filings/0001104659-26-024523.md) | [2.1](/filings/0001558370-25-006869.md) | [1.3 d](/filings/0001558370-25-010682.md) | [1.5 d](/filings/0001104659-25-107626.md) | [0.9 d](/filings/0001104659-26-024523.md) | [1.6](/filings/0001104659-26-057076.md) | [3.3 d](/filings/0001104659-26-092605.md) | [2.5 d](/filings/0001104659-25-107626.md) | [(0.3) d](/filings/0001104659-26-024523.md) | [4.9](/filings/0001104659-26-057076.md) | [1.2 d](/filings/0001104659-26-092605.md) |
| Dividends paid | $m | [7.3 d](/filings/0001558370-24-014810.md) | [7.2 d](/filings/0001104659-26-024523.md) | [7.1](/filings/0001558370-25-006869.md) | [7.8 d](/filings/0001558370-25-010682.md) | [7.8 d](/filings/0001104659-25-107626.md) | [7.8 d](/filings/0001104659-26-024523.md) | [7.8](/filings/0001104659-26-057076.md) | [8.7 d](/filings/0001104659-26-092605.md) | [8.7 d](/filings/0001104659-25-107626.md) | [8.7 d](/filings/0001104659-26-024523.md) | [8.7](/filings/0001104659-26-057076.md) | [9.6 d](/filings/0001104659-26-092605.md) |
| Share repurchases | $m | [9.4 d](/filings/0001558370-24-014810.md) | [4.2 d](/filings/0001104659-26-024523.md) | not reported | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001104659-25-107626.md) | [0.0 d](/filings/0001104659-26-024523.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.0](/filings/0001558370-23-017570.md) | [20.0](/filings/0001558370-24-007501.md) | [19.9](/filings/0001558370-24-011581.md) | [19.8](/filings/0001558370-24-014810.md) | [19.7](/filings/0001558370-25-006869.md) | [19.7](/filings/0001558370-25-010682.md) | [19.7](/filings/0001104659-25-107626.md) | [19.8](/filings/0001104659-26-057076.md) | [19.8](/filings/0001104659-26-092605.md) | [19.8](/filings/0001104659-25-107626.md) | [19.8](/filings/0001104659-26-057076.md) | [19.9](/filings/0001104659-26-092605.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.